VRTX
Vertex Pharmaceuticals Incorporated · Healthcare
SVP and Chief Accounting Officer Paul M Silva sold $588K of Vertex Pharmaceuticals Incorporated
Sold$588,255
$211.45Price
2,782Shares
−22%Stake
What VRTX did after the filing
- The stock from Tue, Mar 2 close, $212.06
- +2.4%
- S&P 500, same days
- +6.8%
Measured over 30 trading days, to the Apr 14 close.
Traded Mon, Mar 1. Filed Tue, Mar 2, 11:07 AM ET, during the session. Returns use the Mar 2 close and the Apr 14 close. Not investment advice.